↓ Skip to main content

Neuroprotection for treatment of glaucoma in adults

Overview of attention for article published in this source, February 2013
Altmetric Badge

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
111 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Neuroprotection for treatment of glaucoma in adults
Published by
John Wiley & Sons, Ltd, February 2013
DOI 10.1002/14651858.cd006539.pub3
Pubmed ID
Authors

Sena, Dayse F, Lindsley, Kristina

Abstract

Glaucoma is a heterogeneous group of conditions involving progressive damage to the optic nerve, deterioration of retinal ganglion cells and ultimately visual field loss. It is a leading cause of blindness worldwide. Open angle glaucoma (OAG), the commonest form of glaucoma, is a chronic condition that may or may not present with increased intraocular pressure (IOP). Neuroprotection for glaucoma refers to any intervention intended to prevent optic nerve damage or cell death.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
United Kingdom 1 <1%
Brazil 1 <1%
United States 1 <1%
Unknown 107 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 37 33%
Student > Master 30 27%
Student > Ph. D. Student 21 19%
Unspecified 17 15%
Student > Bachelor 17 15%
Other 55 50%
Readers by discipline Count As %
Medicine and Dentistry 88 79%
Unspecified 22 20%
Agricultural and Biological Sciences 15 14%
Pharmacology, Toxicology and Pharmaceutical Science 12 11%
Neuroscience 7 6%
Other 33 30%